Global Cryopreservation Cell Lines Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Serum-Containing Medium, Serum-Free Medium, Cry Vials, and Reagents

By Application;

Oncology, Immunology, Cell Biology, and Others

By End User;

Diagnostic Laboratories, Biopharmaceutical Companies, and Academic & Research Institutes

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn792178799 Published Date: June, 2025 Updated Date: July, 2025

Cryopreservation Cell Lines Market Overview

Cryopreservation Cell Lines Market (USD Million)

Cryopreservation Cell Lines Market was valued at USD 14,972.28 million in the year 2024. The size of this market is expected to increase to USD 61,978.42 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 22.5%.


Global Cryopreservation Cell Lines Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 22.5 %


Study Period2025 - 2031
Base Year2024
CAGR (%)22.5 %
Market Size (2024)USD 14,972.28 Million
Market Size (2031)USD 61,978.42 Million
Market ConcentrationLow
Report Pages340
14,972.28
2024
61,978.42
2031

Major Players

  • Thermo Fisher Scientific, Inc
  • ATCC, Corning Incorporated
  • ABM Inc
  • Zenbio
  • REPROCELL USA Inc

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Cryopreservation Cell Lines Market

Fragmented - Highly competitive market without dominant players


The Cryopreservation Cell Lines Market is experiencing substantial growth as over 60% of research institutions and biotechnology companies now rely on cryopreservation techniques to store and maintain biological samples. This method ensures the long-term stability of cell lines, supporting critical research and drug discovery processes. The growing demand for sample preservation has created vast opportunities for innovation and development in this space.

Technological Advancements Driving Innovation
Significant progress in freezing technologies and cryoprotectants has accelerated the adoption of cryopreservation systems, with more than 55% of laboratories integrating automated storage and retrieval solutions. These technological advancements have improved cell viability post-thaw, which is crucial for high-quality research. Continuous innovation is fostering improved preservation strategies, enabling laboratories to meet stringent quality standards.

Focus on Expansion and Infrastructure Scaling
With more than 58% of bioscience organizations expanding their storage facilities, the market is witnessing a sharp uptick in infrastructure development. This expansion is aimed at meeting the escalating demand from pharma, biotech, and academic institutions. Investment in cryopreservation infrastructure is becoming a central strategy for ensuring sustained growth and service delivery across the value chain.

Future Outlook and Market Opportunities
The future outlook for the Cryopreservation Cell Lines Market is promising, as demand for stable, viable samples continues to rise across various sectors. Over 65% of stakeholders are actively exploring opportunities in regenerative medicine, biobanking, and cell-based therapies. These areas hold immense potential for market expansion, driven by the rising importance of reproducible research and precision medicine.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Cryopreservation Cell Lines Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Demand for Biopharmaceuticals
        2. Advancements in Regenerative Medicine
        3. Growing Biobanking Activities
      2. Restraints
        1. High Cost of Cryopreservation Technologies
        2. Ethical and Regulatory Challenges
        3. Risk of Cellular Damage
      3. Opportunities
        1. Expansion of Personalized Medicine
        2. Technological Innovations
        3. Emerging Applications in Stem Cell Research
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Cryopreservation Cell Lines Market,By Product Type, 2021 - 2031 (USD Million)
      1. Serum-Containing Medium
      2. Serum-free Medium
      3. Cry vials
      4. Reagents
    2. Cryopreservation Cell Lines Market, By Application, 2021 - 2031 (USD Million)
      1. Oncology
      2. Immunology
      3. Cell Biology
      4. Others
    3. Cryopreservation Cell Lines Market, By End User, 2021 - 2031 (USD Million)
      1. Diagnostic Laboratories
      2. Biopharmaceutical Companies
      3. Academic & Research Institutes
    4. Cryopreservation Cell Lines Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Thermo Fisher Scientific, Inc
      2. ATCC, Corning Incorporated
      3. ABM Inc
      4. Zenbio
      5. REPROCELL USA Inc
  7. Analyst Views
  8. Future Outlook of the Market